- Cantourage is further expanding its product portfolio with the Canadian cultivator LOT420.
- The new cultivar on the German market "Gelato33" offers patients an alternative therapy option.
- LOT420 focuses on consistent product quality and the cultivation of rare genetics.
Berlin, 14 March 2023 - Another premium strain from the "Craft Cannabis" segment is available on the German medicinal cannabis market. The Berlin based cannabis company Cantourage is expanding its product range with the cultivar "Gelato33" from the Canadian cultivator LOT420. By making their first entry in the European medical cannabis market, LOT420 now provides patients in Germany and other parts of Europe with additional therapeutic options.
LOT420 is a licensed cannabis producer located in the southeast of Montreal. In a total area of approximately 2,000 m², a team of over 30 experienced cannabis growers are dedicated to cultivating select cannabis strains. Through years of experience and optimisation, the company has developed proven methods that consistently deliver high-quality products. In addition to reliable top-quality, LOT420 also prioritises the cultivation of exceptional genetics, demonstrating their commitment to providing unique and exceptional products.
Bernhard Retzer, Global Director of Sales, commented: “As the leading provider of medical cannabis in Europe, we are excited to add LOT420, one of the great brands of the Canadian cannabis market, to our product range. The launch is once again the result of our commitment to bring the products of the best-in-class cannabis cultivators from around the world to Europe, offering more treatment options for patients.“
Stefan Macdonald, CEO von LOT420, added: “Our pursuit of the highest product quality, a deep-rooted respect for nature and a passion for our daily work are the keys to success in growing our premium cannabis. We are committed to excellence in everything we do, and together with Cantourage, we are excited to now bring the results of our work to Germany and Europe.“
About Cantourage
Cantourage is a leading European medical cannabis company. The Berlin-based company with subsidiaries in the United Kingdom and Poland, was founded in 2019 by industry pioneers Norman Ruchholtz, Dr. Florian Holzapfel and Patrick Hoffmann. Cantourage enables producers from all over the world to become part of the rapidly growing European medical cannabis market in a faster and more cost-effective way, while guaranteeing and developing the highest European quality standards. The company offers products in all relevant market segments: dried flowers, extracts, Dronabinol and pharma-grade Cannabidiol.
About LOT420
LOT420 is a licensed cannabis producer located in the Eastern Townships of Quebec that grows high-quality cannabis on a total area of around 2,000 m². The team of more than 30 employees has decades of experience in organic gardening and farming. With their individual expertise for each phase of cultivation, the growers focus with great passion on the cultivation of selected cannabis varieties. The conviction to work in the service of nature, highest care as well as the self-declared company goal to offer only the best products on the market are at the core of their actions. Methods that have been improved over the years and constant process optimisations also ensure the consistently high quality of the products.
Learn more: https://www.lot420.com/
Press contact Cantourage:
Frederick Steudemann
M +49 (0)30 4701 350-50
pr@cantourage.com
